Literature DB >> 671583

Sequence complexity and relative abundance of vaccinia virus mRNA's synthesized in vivo and in vitro.

R F Boone, B Moss.   

Abstract

The sequence complexity and relative abundance of vaccinia virus mRNA's, synthesized in vivo and in vitro, have been measured by DNA-RNA hybridization. Up to 42% of [3H]thymidine-labeled virus DNA can be protected from digestion with nuclease S1, a single-strand specific nuclease, after annealing to excess polyadenylylated mRNA obtained at 7 h after infection. In contrast, only 26% of vaccinia virus DNA is protected when hybridized to polyadenylylated RNA obtained at 2 h after infection in the presence of an inhibitor of DNA synthesis. That the 94 kilobases transcribed early are a subset of the 152 kilobases present late was suggested by hybridization of DNA with a mixture of early and late RNAs. Some control of transcription is lost when virus purified by procedures that include sonic treatment is used for infection since under these conditions similar proportions of DNA are protected by either excess early or late RNA. Excess RNA, synthesized in vitro by enzymes within purified vaccinia virus particles, hybridized to approximately the same fraction of the DNA as did RNA present at late times in vivo. A second type of transcriptional control was demonstrated by kinetic analysis of the hybridization of polyadenylylated RNA to labeled DNA. With virion DNA used as the probe, a single abundance class for early RNA, two classes differing 11-fold in abundance for late RNA, and two classes differing 43-fold in abundance for in vitro RNA were found. To be able to detect high-abundance RNAs of very low sequence complexity, labeled complementary DNA probes to early, late, and in vitro polyadenylylated RNA were used. Evidence that, at late times, RNAs totaling 9 kilobases of sequence complexity are present 40 to 500 times more frequently than the bulk of the virus-specific RNA was obtained. In contrast, the highest abundance class of RNA present at 2 h after infection corresponded to 7 kilobases present in only a 13-fold molar excess over the majority of virus-specific sequences. RNA synthesized in vitro was found to contain a small amount of sequence information, approximately 2 kilobases, which occurred 150 times more frequently than the majority of viral sequences. Studies using hybridization of viral DNA to labeled complementary DNA probes also suggested that 52 to 59% of the polyadenylylated RNA present at 2 h after infection and 82 to 92% of that at 7 h are virus specific.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 671583      PMCID: PMC525881          DOI: 10.1128/JVI.26.3.554-569.1978

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The messenger RNA sequences in growing and resting mouse fibroblasts.

Authors:  J G Williams; S Penman
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

2.  THE REPLICATION AND COATING OF VACCINIA DNA.

Authors:  W K JOKLIK; Y BECKER
Journal:  J Mol Biol       Date:  1964-12       Impact factor: 5.469

3.  The expression of three abundance classes of messenger RNA in mouse tissues.

Authors:  N D Hastie; J O Bishop
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

4.  Molecular complexity of vaccinia DNA and the presence of reiterated sequences in the genome.

Authors:  L J Grady; E Paoletti
Journal:  Virology       Date:  1977-06-15       Impact factor: 3.616

5.  Adenovirus transcription. V. Quantitation of viral RNA sequences in adenovirus 2-infected and transformed cells.

Authors:  S J Flint; P A Sharp
Journal:  J Mol Biol       Date:  1976-09-25       Impact factor: 5.469

6.  mRNA complexity and egg white protein mRNA content in mature and hormone-withdrawn oviduct.

Authors:  N E Hynes; B Groner; A E Sippel; M C Nguyen-Huu; G Schütz
Journal:  Cell       Date:  1977-08       Impact factor: 41.582

7.  Polyadenylate polymerase from vaccinia virions.

Authors:  B Moss; E N Rosenblum; E Paoletti
Journal:  Nat New Biol       Date:  1973-09-12

8.  Ribonucleic acid isolated by cesium chloride centrifugation.

Authors:  V Glisin; R Crkvenjakov; C Byus
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

9.  Number and distribution of polyadenylated RNA sequences in yeast.

Authors:  L M Hereford; M Rosbash
Journal:  Cell       Date:  1977-03       Impact factor: 41.582

10.  Methylation of newly synthesized viral messenger RNA by an enzyme in vaccinia virus.

Authors:  C M Wei; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

View more
  42 in total

1.  Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing.

Authors:  Zhilong Yang; Daniel P Bruno; Craig A Martens; Stephen F Porcella; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Cell-free translation of purified virion-associated high-molecular-weight RNA synthesized in vitro by vaccinia virus.

Authors:  W Bossart; E Paoletti; D L Nuss
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

3.  Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins.

Authors:  Jeffrey O Langland; John C Kash; Victoria Carter; Matthew J Thomas; Michael G Katze; Bertram L Jacobs
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling.

Authors:  Zhilong Yang; Shuai Cao; Craig A Martens; Stephen F Porcella; Zhi Xie; Ming Ma; Ben Shen; Bernard Moss
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

5.  Transcriptional and translational analysis of the vaccinia virus late gene L65.

Authors:  S L Weinrich; E G Niles; D E Hruby
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

6.  A tandemly-oriented late gene cluster within the vaccinia virus genome.

Authors:  S L Weinrich; D E Hruby
Journal:  Nucleic Acids Res       Date:  1986-04-11       Impact factor: 16.971

7.  Capped poly(A) leaders of variable lengths at the 5' ends of vaccinia virus late mRNAs.

Authors:  B Y Ahn; B Moss
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

8.  Localization and sequence of a vaccinia virus gene required for multiplication in human cells.

Authors:  S Gillard; D Spehner; R Drillien; A Kirn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

9.  Macromolecular synthesis in cells infected by frog virus 3. XII. Viral regulatory proteins in transcriptional and post-transcriptional controls.

Authors:  R Goorha; D B Willis; A Granoff
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

10.  Translation of vaccinia virus and cellular mRNA in cell-free systems prepared from uninfected and vaccinia virus infected L929 cells.

Authors:  P W Tas
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.